Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,376 total articles
Axsome Therapeutics reported a robust first quarter of 2026 with total net product revenue growing 57% year-over-year to $191.2 million. The company highlighted the FDA approval of Auvelity for agitation associated with dementia due to Alzheimer's disease, positioning it as a first-in-class treatment. Axsome expanded its commercial efforts and adde…
Superior Group of Companies, Inc. reported its Q1 2026 results showing net sales increase to $140.9 million from $137.1 million a year ago, with net income turning positive at $0.8 million compared to a net loss previously. EBITDA rose to $4.8 million. The company confirmed its full-year 2026 sales and earnings outlook with net sales expected betwe…
ADMA Biologics announced that the FDA has approved the supplemental Biologics License Application for ASCENIV™, expanding its indication for primary humoral immunodeficiency (PI) to include pediatric patients aged two years and older, down from twelve years. This approval follows the final pediatric assessment study report, fulfilling post-marketin…
Seer, Inc. announced the hiring of Anthony Bazarko as Chief Commercial Officer. Bazarko brings over 20 years of leadership experience in life sciences and diagnostics, including prior executive roles at Biologos and Specific Diagnostics. At Seer, he will lead Sales, Marketing, and Customer Experience to boost adoption of Seer's Proteograph® Product…
SOLV Energy announced its agreement to acquire Roberson Waite Electric, a California-based utility substation construction and services provider. This acquisition expands SOLV’s capabilities into the regulated utility market, enhancing its service offerings in grid modernization and resilience, and supports its long-term growth strategy.
Haleon, a global consumer health leader, has introduced the newly reformulated Centrum Adults 50+ Complete Multivitamin in Canada, designed to support nutritional needs and cognitive health of adults aged 50 and over. The formulation is backed by clinical trials demonstrating memory and brain health benefits, continuing Haleon's commitment to scien…
Seres Therapeutics announced preclinical data supporting SER-603, a novel live biotherapeutic candidate designed to target microbial functions linked to mucosal healing and inflammation in inflammatory bowel disease (IBD). Presented at Digestive Disease Week 2026, the data demonstrate SER-603’s potential for precise modulation of inflammatory pathw…
Tilray's craft beer brand 10 Barrel Brewing introduces two new ready-to-drink cocktails—Clean Slate, a non-alcoholic functional beverage infused with vitamins and natural energizers, and Salty Sips, a low-sugar, low-ABV vodka cocktail. These products target changing consumer preferences towards functional, health-conscious drinks and aim to expand …
Prospect Capital Corporation, a US-based business development company, has completed a $26 million investment in Security Fire Systems, collaborating with Blackford Capital. The investment includes a senior secured term loan and preferred equity to finance SFS's growth and acquisition plans in the fire suppression industry across multiple states an…
Krystal Biotech announced robust financial results for Q1 2026, including a 32% increase in global revenue for its gene therapy product VYJUVEK, totaling $116.4 million. The company completed enrollment in a key ophthalmology clinical study and is on track for multiple registrational data readouts this year. It also received FDA platform technology…
Legence Corp. plans to release its first quarter 2026 financial results on May 14, 2026 before market open. The company will host a webcast and conference call to discuss the results and operations with investors and the public. The webcast and related materials will be available on Legence's investor relations website, with a replay accessible for…
Cibus, Inc. has transferred gene-edited herbicide tolerance traits in rice to its partner Interoc to begin testing and production, ahead of planned commercialization in Latin America. The collaboration leverages Cibus' rapid trait development technology to address agricultural productivity and sustainability, with further gene-edited traits expecte…
Tenax Therapeutics has named Timothy Healey as their new Chief Commercial Officer. He brings substantial pharmaceutical commercial leadership experience, having led successful drug launches at prominent biopharma companies. Healey will oversee the global commercial strategy and prepare the company for the launch of TNX-103, an innovative therapy be…
BioCryst Pharmaceuticals has entered into an exclusive licensing agreement with Neopharmed Gentili's Irish affiliate granting rights to commercialize navenibart, a Phase 3 investigational treatment for hereditary angioedema, in Europe. The deal includes $70 million upfront, up to $275 million in milestone payments, and tiered royalties, strengtheni…
Bowman Consulting Group Ltd. (NASDAQ: BWMN) has acquired Smith & Associates Land Surveying, LLC, a Las Vegas-based land surveying firm with over 30 years of experience. The acquisition enhances Bowman's presence in the growing Southwest U.S. market, adds specialized surveying capabilities, and is expected to contribute approximately $2 million in a…
Descartes Systems Group announced it will release its first quarter fiscal 2027 financial results after market close on June 3, 2026. The company's executive management will discuss the results during a conference call and webcast on the same day. Descartes is a global leader in logistics technology, connecting shippers, carriers, and logistics pro…
Cabaletta Bio, a Nasdaq-listed clinical-stage biotech company developing targeted cell therapies for autoimmune diseases, has priced a $150 million underwritten offering of 51.7 million shares at $2.90 each. The offering, supported by current investors including Bain Capital Life Sciences and Eli Lilly, is expected to close by May 5, 2026, and proc…
ADT Inc. announced a secondary offering of approximately 102 million shares held by Apollo Global Management affiliates, with the company not selling shares or receiving proceeds. Concurrently, ADT plans to repurchase up to about 29 million shares under its $1.5 billion repurchase plan. The offering is managed by Barclays and Citigroup and register…
Norwegian Cruise Line Holdings Ltd. reported a 10% increase in Q1 2026 revenue to $2.3 billion and more than doubled its adjusted net income to $108 million, with adjusted EPS rising to $0.23. Despite exceeding quarterly guidance and achieving $125 million in annualized SG&A savings, the company lowered its full year 2026 adjusted EPS guidance to a…
Parsons Corporation has been awarded a 9-month contract by The Boring Company to provide professional and program management services for the Dubai Loop, an innovative underground passenger transportation initiative in Dubai. Parsons will oversee design verification, stakeholder management, permitting support, and multidisciplinary reviews to ensur…
AH Realty Trust announced the execution of a 22,000-square-foot long-term office lease at its mixed-use property Southern Post with Industrious, a global leader in workplace experience. Industrious will occupy about 1.5 floors and provide 241 office and access seats. This lease brings Southern Post's office occupancy to 83.5%, reinforcing AH Realty…
Aura Biosciences, a clinical-stage biotechnology company specializing in precision therapies for solid tumors, announced a proposed public offering of common stock and pre-funded warrants. The offering aims to raise capital to support Aura's continued development of its lead oncology candidate, bel-sar (AU-011), currently in late-stage trials for c…
Aura Biosciences announced the appointment of Natalie Holles as CEO and President, coinciding with the nearing completion of patient enrollment in its pivotal Phase 3 CoMpass trial for belzupacap sarotalocan (bel-sar), a potential first frontline, vision-preserving therapy for early choroidal melanoma. The company maintains guidance for enrollment …
Global Net Lease, Inc. (NYSE: GNL) announced it will acquire Modiv Industrial, Inc. (NYSE: MDV) in an all-stock transaction valued at approximately $535 million. The acquisition is expected to be immediately accretive to GNL's AFFO per share by 4%, leverage-neutral, and enhance portfolio quality by adding high-quality industrial net lease assets wi…
KBR Inc. announced that its Mission Technology Solutions division received two task order modifications totaling $449 million under the U.S. Army's Logistics Civil Augmentation Program (LOGCAP) V. The awards include a $304 million contract for logistics and mission-critical infrastructure support in Europe and a $145 million contract for maintenanc…
